Inantol 25 micrograms/125 micrograms inhalation suspension in a pressurised container
Inantol 25 micrograms/250 micrograms inhalation suspension in a pressurised container
salmeterol/fluticasone propionate
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
This medication contains two active substances, salmeterol and fluticasone propionate:
This medication is indicated only for adults 18 years or older.
This medication is not indicated for use in children 12 years or younger, or adolescents between 13 and 17 years.
Your doctor has prescribed this medication to help prevent respiratory problems such as asthma.
You should use this medication every day as directed by your doctor. This will ensure that the medication works correctly to control your asthma.
Do not use Inantol:
If you are allergic to salmeterol, fluticasone propionate, or any of the other ingredients of this medication (listed in section 6).
Warnings and precautions
Consult your doctor before starting to use this medication if you have:
Contact your doctor if you experience blurred vision or other visual disturbances.
Children and adolescents
This medication should not be used in children and adolescents under 18 years.
Other medications and Inantol
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medications, including those for asthma or those purchased without a prescription. The reason is that, in some cases, Inantol should not be administered with other medications.
Tell your doctor if you are taking the following medications before starting to use Inantol:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and using machines
It is unlikely that this medication will affect your ability to drive or use machines.
Inantol contains ethanol
This medication contains 1.5 mg of alcohol (ethanol) per dose, equivalent to 12.2 mg/ml. The amount of this medication in a dose is equivalent to less than 0.04 ml of beer or 0.01 ml of wine.
The small amount of alcohol in this medication does not produce any noticeable effect.
Follow the instructions for administration of this medication exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist.
Adults
Inantol 25/125 - 2 inhalations twice a day
Inantol 25/250 - 2 inhalations twice a day
Your symptoms may be well-controlled using this medication twice a day. If so, your doctor may decide to reduce your dose to once a day. The dose may change to:
It is very important that you follow your doctor's instructions on how many applications and how often to administer them.
If you are using this medication to treat asthma, your doctor will want to regularly monitor your symptoms. If your asthma worsens or you have more difficulty breathing, see your doctor immediately. You may notice more wheezing or a feeling of shortness of breath more often, or you may need to use your fast-acting "rescue" medication more frequently. If any of these things happen, you should continue using Inantol, but do not increase the number of applications. Your respiratory disease may worsen and become serious. See your doctor, as you may need additional treatment.
Instructions for use
Checking the inhaler
Using the inhaler
It is essential to start inhaling as slowly as possible just before using your inhaler.
Take your time in steps 4, 5, 6, and 7. It is essential that you start inhaling as slowly as possible just before using your inhaler. The first few times you use the inhaler, you should use it in front of a mirror. If you see "mist" coming out of the top of the inhaler or the sides of your mouth, you should start again from step 3.
If you find it difficult to use the inhaler, your doctor or another healthcare professional may recommend using the inhaler with a spacer, such as AeroChamber Plus®. Your doctor, nurse, pharmacist, or other healthcare professional should show you how to use the spacer with your inhaler, how to maintain your spacer, and answer any questions you may have. If you are using the spacer with your inhaler, it is essential that you do not stop using it without consulting your doctor or nurse first. Only the AeroChamber Plus®spacer should be used with Inantol.Other spacers should not be used with Inantol, and you should not switch from one spacer to another.If you stop using the spacer, your doctor may need to change the dose of medication needed to control your asthma. Always consult your doctor before making any changes to your asthma treatment.
People with little hand strength may find it easier to hold the inhaler with both hands. Place your two index fingers on the top of the inhaler and both thumbs on the base, below the mouthpiece.
You should get a replacement inhaler when the marker indicates 20 (figure 6). Stop using the inhaler when the marker indicates 0, as the applications left in the container may not be sufficient to complete a dose. Never try to modify the numbering on the marker or detach the marker from the plastic container.
Cleaning the inhaler
To prevent the inhaler from becoming blocked, it is essential to clean it at least once a week.
To clean the inhaler:
Do not wash or put any part of the inhaler in water.
If you use more Inantol than you should
It is very important to use the inhaler exactly as directed. If you accidentally take a higher dose than recommended, consult your doctor or pharmacist. You may notice that your heart beats faster than normal and feel tremors. You may also experience dizziness, headache, muscle weakness, and joint pain.
If you have used large doses for extended periods, you should ask your doctor or pharmacist for advice. This is because high concentrations of this medication may reduce the amount of steroid hormones produced by the adrenal gland.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to use Inantol
Do not take a double dose to make up for forgotten doses. Take the next dose at the usual time.
If you stop using Inantol
It is very important that you use this medication every day as directed. Continue to take it until your doctor tells you to stop. Do not stop using this medication suddenly or reduce the dose.This could cause your breathing to worsen.
Additionally, if you stop taking this medication suddenly or reduce the dose, you may (very rarely) experience problems with your adrenal gland (adrenal insufficiency), which can sometimes cause side effects.
These side effects may include:
When your body is under stress, such as fever, trauma (e.g., car accident), infection, or surgery, adrenal insufficiency may worsen, and you may experience any of the above side effects.
If you experience any side effects, consult your doctor or pharmacist. To prevent these symptoms, your doctor may prescribe an additional dose of corticosteroids in tablets during that time (such as prednisolone).
If you have any further questions about the use of this medication, ask your doctor, nurse, or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. To reduce the appearance of adverse effects, your doctor will prescribe the lowest dose of this medicine that controls your asthma.
Allergic Reactions: you may notice that your breathing suddenly worsens immediately after using Inantol. You may suffer from wheezing and coughing or shortness of breath. You may also notice itching, skin rash (urticaria), and swelling (usually in the face, lips, tongue, or throat). You may also suddenly feel that your heart is beating very fast, feel like you are losing consciousness, and feel dizzy (which can lead to collapse or loss of consciousness). If you experience any of these effects or if they appear suddenly after using this medicine, stop taking it and inform your doctor immediately.Allergic reactions to this medicine are rare (affect less than 1 in 100 people).
The following are other adverse effects:
Very Common (may affect more than 1 in 10 people)
Common (may affect less than 1 in 10 people)
The following adverse effects have been reported in patients with Chronic Obstructive Pulmonary Disease (COPD):
Uncommon (may affect less than 1 in 100 people)
Rare (may affect less than 1 in 1,000 people)
Frequency not known, but may also appear:
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the label and on the cardboard box after "CAD" or "EXP". The expiration date is the last day of the month indicated.
No special storage conditions are required.
The container contains a pressurized liquid. Do not expose to temperatures above 50°C, protect from direct sunlight. Do not puncture or burn the container, even if it is empty.
As with most inhalation medicines in pressurized containers, the therapeutic effect of this medicine may decrease if the container is cold.
Medicines should not be thrown away in drains or in the trash. Deposit the containers and medicines you no longer need in the SIGRE point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the containers and medicines you no longer need. This way, you will help protect the environment.
Inantol Composition
Each pressurized dose (released from the valve) contains 25 micrograms of salmeterol (as salmeterol xinafoate) and 125 or 250 micrograms of fluticasone propionate. This is equivalent to a released dose (released from the mouthpiece) of 21 micrograms of salmeterol and 110 or 220 micrograms of fluticasone propionate.
The other components are a propellant: norflurane (HFA 134a) and anhydrous ethanol.
Product Appearance and Container Contents
Marketing Authorization Holder:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 - Madrid
Spain
Manufacturer:
Mylan Germany GmbH
Benzstrasse 1
Bad Homburg,
Hesse,
61352,
Germany
or
McDermott Laboratories Limited t/a Gerard Laboratories,
35/36 Baldoyle Industrial Estate,
Grange Road,
Dublin 13,
Ireland
Date of the last revision of this prospectus:October 2023
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/